Impact of continuing folic acid after the first trimester of pregnancy: Findings of a randomized trial of folic acid supplementation in the second and third trimesters

American Journal of Clinical Nutrition

Volumn 98, Issue 1, 2013, Pages 92-98

  McNulty, Breige ^a   McNulty, Helene ^a   Marshall, Barry ^b   Ward, Mary ^a   Molloy, Anne M ^c   Scott, John M ^d   Dornan, James ^e   Pentieva, Kristina ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FEMALE; FIRST TRIMESTER PREGNANCY; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN TISSUE; MATERNAL NUTRITION; NEWBORN; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ERYTHROCYTES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INFANT, NEWBORN; INTERVENTION STUDIES; MALE; NEURAL TUBE DEFECTS; NORTHERN IRELAND; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; YOUNG ADULT;

EID: 84879428840     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.057489     Document Type: Article

References (51)

1. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Council Vitamin Study. Lancet 1991;338: 131-7.
3. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 1992;41:1-7.
4. Department of Health. Folic acid and the prevention of neural tube defects. Report from an expert advisory group. Heywood, United Kingdom: DOH Health Publication Unit, 1992:21.
5. Wills L. Treatment of "pernicious anaemia of pregnancy" and "tropical anaemia" with special reference to yeast extract as a curative agent. BMJ 1931;1:1059-64.
6. Chanarin I, Rothman D, Ward A, Perry J. Folate status and requirement in pregnancy. BMJ 1968;2:390-4.
7. Hall MH, Pirani BB, Campbell D. The cause of the fall in serum folate in normal pregnancy. Br J Obstet Gynaecol 1976;83:132-6.
8. Chanarin I. Folate and cobalamin. Clin Haematol 1985;14:629-41.
9. Fletcher J, Gurr A, Fellingham FR, Prankerd TA, Brant HA, Menzies DN. The value of folic acid supplements in pregnancy. J Obstet Gynaecol Br Commonw 1971;78:781-5.
10. Blot I, Papiernik E, Kaltwasser JP, Werner E, Tchernia G. Influence of routine administration of folic acid and iron during pregnancy. Gynecol Obstet Invest 1981;12:294-304.
11. McNulty H, McPartlin JM, Weir DG, Scott JM. Folate catabolism is increased during pregnancy in rats. J Nutr 1993;123:1089-93.
12. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG. Accelerated folate breakdown in pregnancy. Lancet 1993;341:148-9.
13. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a metaanalysis of the randomized trials. Am J Clin Nutr 2005;82:806-12.
14. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:149-51.
15. Felkner M, Suarez L, Canfield MA, Brender JD, Sun Q. Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border population. Birth Defects Res A Clin Mol Teratol 2009;85:574-81.
16. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001;185:781-5.
17. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of nonsevere preeclampsia. Am J Obstet Gynecol 2003;189:391-4.
18. Goddijn-Wessel TA, Wouters MG, van de Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, Boers GH, Eskes TK. Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996;66:23-9.
19. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000;74:1196-9.
20. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr 2000;71:962-8.
21. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, Cocchi G, de Vigan C, de Walle H, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005;330:571-3.
22. McNulty B, Pentieva K, Marshall B, Ward M, Molloy AM, Scott JM, McNulty H. Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Hum Reprod 2011;26:1530-6.
23. Nilsen RM, Vollset SE, Gjessing HK, Magnus P, Meltzer HM, Haugen M, Ueland PM. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. Am J Clin Nutr 2006;84:1134-41.
24. Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 1997;281:43-53.
25. Kelleher BP, Broin SDO. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991;44:592-5.
26. Leino A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx analyzer. Clin Chem 1999;45: 569-71.
27. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boeurs GJH, den Heijer M, Kluijtmans LAJ, Van den Heuvel LP, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
28. Holmes VA, Wallace JM, Alexander HD, Gilmore WS, Bradbury I, Ward M, Scott JM, McFaul P, McNulty H. Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. Clin Chem 2005;51:629-34.
29. Research DSS. Available from: http://www.dssresearch.com/toolkit/sscalc/ size-a2.asp (cited 15 July 2011).
30. Department of Health. Dietary reference values for food energy and nutrients for the United Kingdom. London, United Kingdom: The Stationary Office, 1991:41.
31. Chanarin I. The megaloblastic anaemias. In: Megaloblastic anaemia associated with pregnancy. London, United Kingdom: Blackwell, 1969:786-829.
32. Andersson A, Hultberg B, Brattstrom L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 1992;30:377-9.
33. Murphy MM, Scott JM, Arija V, Molloy AM, Fernandez-Ballart JD. Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. Clin Chem 2004;50:1406-12.
34. Baksu A, Taskin M, Goker N, Baksu B, Uluocak A. Plasma homocysteine in late pregnancies complicated with preeclampsia and in newborns. Am J Perinatol 2006;23:31-5.
35. Onalan R, Onalan G, Gunenc Z, Karabulut E. Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction. Gynecol Obstet Invest 2006;61:142-8.
36. Ayar A, Celik H, Ozcelik O, Kelestimur H. Homocysteine-induced enhancement of spontaneous contractions of myometrium isolated from pregnant women. Acta Obstet Gynecol Scand 2003;82:789-93.
37. Wilcox AJ. On the importance-and the unimportance-of birthweight. Int J Epidemiol 2001;30:1233-41.
38. Chanarin I, Rothman D. Further observations on the relation between iron and folate status in pregnancy. BMJ 1971;2:81-4.
39. Baker H, Thind IS, Frank O, DeAngelis B, Caterini H, Louria DB. Vitamin levels in low-birth-weight newborn infants and their mothers. Am J Obstet Gynecol 1977;129:521-4.
40. Relton CL, Pearce MS, Parker L. The influence of erythrocyte folate and serum vitamin B12 status on birth weight. Br J Nutr 2005;93:593-9.
41. Takimoto H, Mito N, Umegaki K, Ishiwaki A, Kusama K, Abe S, Yamawaki M, Fukuoka H, Ohta C, Yoshiike N. Relationship between dietary folate intakes, maternal plasma total homocysteine and B-vitamins during pregnancy and fetal growth in Japan. Eur J Nutr 2007;46:300-6.
42. Parazzini F, Chiaffarino F, Ricci E, Improta L, Monni G. Homocysteine, red cell and plasma folate concentrations and birth weight in Italian women: results from a prospective study. J Matern Fetal Neonatal Med 2011;24:427-31.
43. Tamura T, Goldenberg RL, Freeberg LE, Cliver SP, Cutter GR, Hoffman HJ. Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am J Clin Nutr 1992;56:365-70.
44. Timmermans S, Jaddoe VW, Hofman A, Steegers-Theunissen RP, Steegers EA. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and pre-term birth: the Generation R Study. Br J Nutr 2009;102:777-85.
45. Palma S, Perez-lglesias R, Prieto D, Pardo R, Llorca J, Delgado-Rodriguez M. Iron but not folic acid supplementation reduces the risk of low birthweight in pregnant women without anaemia: a case-control study. J Epidemiol Community Health 2008;62:120-4.
46. Hoey L, McNulty H, Askin N, Dunne A, Ward M, Pentieva K, Strain JJ, Molloy AM, Flynn CA, Scott JM. Impact of a voluntary food fortification policy on folate, related B-vitamin status and homocysteine in healthy adults. Am J Clin Nutr 2007;86:1405-13.
47. Bailey RL, Dodd KW, Gahche JJ, Dwyer JT, McDowell MA, Yetley EA, Sempos CA, Burt VL, Radimer KL, Picciano MF. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003-2006. Am J Clin Nutr 2010;91:231-7.
48. Choi SW, Friso S. Epigenetics: a new bridge between nutrition and health. Adv Nutr 2010;1:8-16.
49. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J, Siebel C, Steegers EA, Slagboom PE, Heijmans BT. Periconceptional maternal folic acid use of 400 μg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS ONE 2009;4:e7845.
50. Hoyo C, Murtha AP, Schildkraut JM, Jirtle RL, Demark-Wahnefried W, Forman MR, Iversen ES, Kurtzberg J, Overcash F, Huang Z, et al. Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy. Epigenetics 2011;6:928-36.
51. Fryer AA, Emes RD, Ismail KM, Haworth KE, Mein C, Carroll WD, Farrell WE. Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans. Epigenetics 2011;6:86-94.